IGHV测序揭示获得性N-糖基化位点是滤泡性淋巴瘤演化中的克隆性稳定事件
滤泡性淋巴瘤B细胞持续发生免疫球蛋白可变区基因的体细胞超突变,可产生编码N-糖基化位点的序列。本研究通过下一代测序追踪多样患者群体中N-糖基化位点在肿瘤演化和进展中的行为。超过96%的亚克隆群体在诊断、进展和转化事件中保留N-糖基化位点,而N-糖基化阴性亚克隆被丢失或可忽略,表明肿瘤细胞依赖这些位点。
要点
- N-糖基化位点在超过96%的亚克隆中跨诊断、进展和转化事件保守。
- N-糖基化阴性亚克隆在连续事件中被丢失或可忽略。
- N-糖基化位点在最早识别的淋巴瘤细胞中获得,是发病早期且稳定的事件。
核心结论
- N-糖基化位点是滤泡性淋巴瘤演化中早期获得且稳定的克隆性事件,肿瘤细胞依赖其存在。
研究设计与样本
- 通过下一代测序追踪多样患者群体中N-糖基化位点在肿瘤演化和进展中的行为。
- 基于亚克隆间体细胞超突变相似性及与胚系序列差异构建谱系树可视化亚克隆层级。
主要发现
- 超过96%的亚克隆群体在诊断、进展和转化事件中保留N-糖基化位点。
- 罕见的N-糖基化阴性亚克隆在连续事件中被丢失或可忽略。
- N-糖基化阳性亚克隆可在解剖部位间迁移。
- N-糖基化位点持续体细胞超突变导致不同疾病事件中亚克隆氨基酸组成不同,但绝大多数DNA序列仍编码N-糖基化位点。
- N-糖基化位点在最早识别的淋巴瘤细胞中获得。
临床怎么用
- 靶向推断的甘露糖-凝集素相互作用具有治疗前景。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Follicular lymphoma B cells undergo continuous somatic hypermutation (SHM) of their immunoglobulin variable region genes, generating a heterogeneous tumor population. SHM introduces DNA sequences encoding N-glycosylation sites asparagine-X-serine/threonine (N-gly sites) within the V-region that are rarely found in normal B-cell counterparts. Unique attached oligomannoses activate B-cell receptor signaling pathways after engagement with calcium-dependent lectins expressed by tissue macrophages. This novel interaction appears critical for tumor growth and survival. To elucidate the significance of N-gly site presence and loss during ongoing SHM, we tracked site behavior during tumor evolution and progression in a diverse group of patients through next-generation sequencing. A hierarchy of subclones was visualized through lineage trees based on SHM semblance between subclones and their discordance from the germline sequence. We observed conservation of N-gly sites in more than 96% of subclone populations within and across diagnostic, progression, and transformation events. Rare N-gly-negative subclones were lost or negligible from successive events, in contrast to N-gly-positive subclones, which could additionally migrate between anatomical sites. Ongoing SHM of the N-gly sites resulted in subclones with different amino acid compositions across disease events, yet the vast majority of resulting DNA sequences still encoded for an N-gly site. The selection and expansion of only N-gly-positive subclones is evidence of the tumor cells' dependence on sites, despite the changing genomic complexity as the disease progresses. N-gly sites were gained in the earliest identified lymphoma cells, indicating they are an early and stable event of pathogenesis. Targeting the inferred mannose-lectin interaction holds therapeutic promise.
引用
- Odabashian M, Carlotti E, Araf S, et al. IGHV sequencing reveals acquired N-glycosylation sites as a clonal and stable event during follicular lymphoma evolution. Blood. 2020. PMID: 31932843. doi:10.1182/blood.2019002279
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。